X-Therma logo

News

X-Therma is granted by U.S. Department of Defense for Phase I research

X-Therma is granted by U.S. Department of Defense for Phase I research on developing breakthrough cryoprotective agents (CPAs) for large organ/tissue cryopreservation!

X-Therma is granted by U.S. Department of Defense for Phase I research on developing breakthrough cryoprotective agents (CPAs) for large organ/tissue cryopreservation!

Find the whole article here:

This article is posted on Scientific American
NORTH AMERICA

2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA

EUROPE

Kaiserjägerstraße 30
6020 Innsbruck
Austria